Published on 26 Sep 2023 on Simply Wall St. via Yahoo Finance
Immutep Limited (ASX:IMM): Is Breakeven Near?
Immutep Limited (ASX:IMM) is possibly approaching a major achievement in its business, so we would like to shine some light on the company. Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical products. The AU$350m market-cap company announced a latest loss of AU$40m on 30 June 2023 for its most recent financial year result. The most pressing concern for investors is Immutep's path to profitability – when will it breakeven? Below we will provide a high-level summary of the industry analysts’ expectations for the company.
Check out our latest analysis for Immutep